Scientists have been searching for an antibody that would be broadly neutralizing — able to fight off any viral variant that might emerge.

Novel “Decoy” receptors capture the antibodies and take them out of circulation before they could kill the therapeutic cells.

As the COVID-19 pandemic wears on, newer variants of SARS-CoV-2 have been evolving ways to evade the antibodies our bodies make.

The scientists reveal critical new insights into their novel vaccine strategy, which involves a stepwise approach to producing antibodies.

Scientists have been searching for an antibody that would be broadly neutralizing — able to fight off any viral variant that might emerge.

One injection of a candidate monoclonal antibody (mAb) known as L9LS was found to be safe and highly protective in adults exposed to malaria

As the COVID-19 pandemic wears on, newer variants of SARS-CoV-2 have been evolving ways to evade the antibodies our bodies make.

Scientists have been searching for an antibody that would be broadly neutralizing — able to fight off any viral variant that might emerge.

Researchers develop a nanobody capable of getting through the tough exterior of brain cells and untangling misshapen proteins leading to PD.

One set of antibodies that is induced naturally by gut beneficial bacteria can be transferred from mothers to infants through breastmilk.

New study finds that immunocompromised patients tend to develop chronic coronavirus infections, leading to highly mutated variants.

Dogs are proving to be a far better scientific model for study of prostate cancer than mice, the typical animal used in the lab.

The findings could lead to the development of more effective vaccines and antibody treatments for COVID-19 variants.

It sounds like the stuff of science fiction: a man-made crystal that can attach to antibodies and then supercharge them with potent drugs.

No one knows why some people age worse than others and develop diseases -such as Alzheimer's, type 2 diabetes or some types of cancer.

An unexpected discovery... We were surprised that slowing down our cell biology just a little bit throws virus replication off its game.

Researchers have found a way to enhance the natural ability of therapeutic antibodies to attack blood cancer cells using the immune system.

Scientists are using the precision targeting of monoclonal antibodies for a new type of non-hormonal female contraception.

Alphaviruses — mosquito-borne viruses that can trigger brain infections and arthritis — may have met their match.

The breakthrough has the potential to aid in medical diagnoses and, specifically, those related to the COVID-19 pandemic.